Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia.
Drug Utilization and Pharmacoepidemiology Research Group, Center of Excellence for Pharmaceutical Care Innovation, Universitas Padjadjaran, Jatinangor, Indonesia.
BMC Med Inform Decis Mak. 2024 May 21;24(1):130. doi: 10.1186/s12911-024-02494-3.
In Indonesia, the adoption of telepharmacy was propelled by the COVID-19 pandemic, prompting the need for a user-friendly application to support both the general population and pharmacists in accessing healthcare services. Therefore, this study aimed to evaluate usability and user feedback of a pioneering telepharmacy application known as Tanya Obat (translating to "Ask about Medications") in Indonesia, from the perspectives of the general population and pharmacists.
A mixed-methods sequential study was conducted with the early-stage Tanya Obat application in Bandung City. Participants, including the general population and pharmacists, were instructed to use the application for a week. Questionnaires for the general population and pharmacists were distributed from March to May and February to June 2023, respectively. The System Usability Scale questionnaire was adopted to describe usability of the developed application. Further exploration of the quantitative results required collecting open-ended feedback to assess the impressions of the participants, difficulties encountered, and desired features for enhanced user-friendliness. The collected statements were summarized and clustered using thematic analysis. Subsequently, the association between the characteristics of participants and perceived usability was determined with the Chi-square test.
A total of 176 participants, comprising 100 individuals from the general population and 76 pharmacists, engaged in this study. In terms of usability, the questionnaire showed that Tanya Obat application was on the borderline of acceptability, with mean scores of 63.4 and 64.1 from the general population and pharmacists, respectively. Additionally, open-ended feedback targeted at achieving a more compelling user experience was categorized into two themes, including concerns regarding the functionality of certain features and recommendations for improved visual aesthetics and bug fixes. No significant associations were observed between the characteristics of participants and perceived usability (p-value > 0.05).
The results showed that the perceived usability of Tanya Obat developed for telepharmacy was below average. Therefore, feature optimizations should be performed to facilitate usability of this application in Indonesia.
在印度尼西亚,远程药学的采用是由 COVID-19 大流行推动的,这促使人们需要一个用户友好的应用程序来支持普通民众和药剂师获取医疗服务。因此,本研究旨在从普通民众和药剂师的角度评估印度尼西亚开创性的远程药学应用程序 Tanya Obat(译为“询问药物”)的可用性和用户反馈。
在万隆市进行了一项混合方法的顺序研究,采用早期的 Tanya Obat 应用程序。参与者包括普通民众和药剂师,他们被要求使用该应用程序一周。分别于 2023 年 3 月至 5 月和 2 月至 6 月向普通民众和药剂师分发了问卷。采用系统可用性量表问卷来描述开发应用程序的可用性。为了进一步探索定量结果,需要收集开放式反馈意见,以评估参与者的印象、遇到的困难和增强用户友好性所需的功能。收集到的陈述使用主题分析进行总结和聚类。随后,使用卡方检验确定参与者特征与感知可用性之间的关联。
共有 176 名参与者参与了这项研究,其中包括 100 名普通民众和 76 名药剂师。就可用性而言,问卷显示 Tanya Obat 应用程序处于可接受的边缘,普通民众和药剂师的平均得分为 63.4 和 64.1。此外,针对实现更具吸引力的用户体验的开放式反馈分为两个主题,包括对某些功能的功能的关注和改进视觉美学和错误修复的建议。参与者的特征与感知可用性之间没有观察到显著关联(p 值>0.05)。
结果表明,为远程药学开发的 Tanya Obat 的感知可用性低于平均水平。因此,应进行功能优化,以促进印度尼西亚对该应用程序的可用性。